TAILIEUCHUNG - Chapter 079. Cancer Genetics (Part 2)

General Classes of Cancer Genes There are two major classes of cancer genes. The first class comprises genes that directly affect cell growth either positively (oncogenes) or negatively (tumor-suppressor genes). These genes exert their effects on tumor growth through their ability to control cell division (cell birth) or cell death (apoptosis). Oncogenes are tightly regulated in normal cells. In cancer cells, oncogenes acquire mutations that relieve this control and lead to increased activity of the gene product. This mutational event typically occurs in a single allele of the oncogene and acts in a dominant fashion. In contrast, the normal. | Chapter 079. Cancer Genetics Part 2 General Classes of Cancer Genes There are two major classes of cancer genes. The first class comprises genes that directly affect cell growth either positively oncogenes or negatively tumor-suppressor genes . These genes exert their effects on tumor growth through their ability to control cell division cell birth or cell death apoptosis . Oncogenes are tightly regulated in normal cells. In cancer cells oncogenes acquire mutations that relieve this control and lead to increased activity of the gene product. This mutational event typically occurs in a single allele of the oncogene and acts in a dominant fashion. In contrast the normal function of tumorsuppressor genes is to restrain cell growth and this function is lost in cancer. Because of the diploid nature of mammalian cells both alleles must be inactivated to completely lose the function of a tumor-suppressor gene leading to a recessive mechanism at the cellular level. From these ideas and studies on the inherited form of retinoblastoma Knudson and others formulated the two-hit hypothesis which in its modern version states that both copies of a tumor-suppressor gene must be inactivated in cancer. The second class of cancer genes the caretakers does not directly affect cell growth but rather affects the ability of the cell to maintain the integrity of its genome. Cells with deficiency in these genes have an increased rate of mutations in all the genes including oncogenes and tumor-suppressor genes. This mutator phenotype was first hypothesized by Loeb to explain how the multiple mutational events required for tumorigenesis can occur in the lifetime of an individual. A mutation phenotype has now been observed in cancer at both the nucleotide sequence and chromosomal levels. Mechanisms of Tumor-Suppressor Inactivation The two major types of somatic lesions observed in tumor-suppressor genes during tumor development are point mutations and large deletions. Point mutations in the .

• Y học thường thức
• Cancer Genetics
• bệnh học và điều trị
• bài giảng bệnh học
• tài liệu y khoa
• Harrisons Internal Medicine
• Biological information
• Lecture Genetics
• Human genetics
• Somatic mutation
• Genetics of cancer
• Cell division
• Quantitative genetics
• Population genetics
• Evolutionary genetics
• The genetic code
• Genetics in medicine
• Developmental genetics
• Birth defects
• Cancer genetics and genomics
• Risk assessment
• Genetic counseling
• Prenatal diagnosis and screening
• Personalized health care
• USMLE road map Genetics
• Mitochondrial dysfunction
• Congenital changes
• Genetics and cancer
• Genetics and common diseases
• Surgical Treatment
• Laparoscopic Surgery
• Severe Ulcerative Colitis
• Drug Therapy
• Biologic Drugs
• Ulcerative Colitis
• Chronic Myelogenous Leukemia
• Colorectal Cancer
• Neurodegenerative Diseases
• Teratogenesi
• Medical Genetics
• Diagnostic Techniques
• Basic Genetics
• Breast cancer management
• Gross anatomy
• The breast
• Breast cancer epidemiology
• Hereditary breast cancer genetics
• Prediction techniques
• Breast cancer screening
• HIV infection
• Testicular cancer
• Penile cancer
• associated dermatoses
• Cutaneous melanoma
• Molecular Carcinogenesis
• Molecular Epidemiology
• Cancer Disparities in Appalachia
• Environmental Factors
• Breast Cancer Genetics
• ABC of colorectal cancer
• Clinical genetics
• The surgeon matter
• Adjuvant therapy
• The role of primary care
• BMC Cancer
• Young onset colorectal cancer
• Clinicopathological characteristics
• Genetic referral
• Microsatellite instability
• Breast cancer susceptibility
• Haplotype analysis
• Functional analysis
• Multifocal bladder cancer
• Next generation sequencing
• APOBEC deaminase
• Gynaecological oncology
• Pathogenic sequence variants
• BMC Genetics
• Liver cancer
• RNA sequencing
• Potential molecular mechanism
• Cancer hypoxia